Medicated skin care in vietnam

联系购买电话：010-82863480 公司名称：佐思信息 公司地址：北京市海淀区 苏州街 18 号院长远天地大厦 A2 座 1008-1 室（100080） 2011.5 摘要 About this Report This Euromonitor market report provides market trend and market growth analysis of the Medicated Skin Care industry in Vietnam. With this market report, you’ll be able to explore in detail the changing shape and potential of the industry. You will now be able to plan and build strategy on real industry data and projections. The Medicated Skin Care in Vietnam market research report includes: * Analysis of key supply-side and demand trends * Detailed segmentation of international and local products * Historic volumes and values, company and brand market shares * Five year forecasts of market trends and market growth * Robust and transparent market research methodology, conducted in-country Our market research reports answer questions such as: * What is the market size of Medicated Skin Care in Vietnam? * What are the major brands in Vietnam? * What are the most popular formats for acne treatments? Why buy this report? * Gain competitive intelligence about market leaders * Track key industry trends, opportunities and threats * Inform your marketing, brand, strategy and market development, sales and supply functions This industry report originates from Passport, our Consumer Health market research database. Each report is delivered with the following components: Report: PDF and Word Market statistics: Excel workbook Sample Analysis TRENDS * Improving living standards and higher disposable income stimulated demand for medicated skin care products among middle- and high-income consumers in Vietnam. Moreover, consumers paid more attention to medicated skin care as the environment became more and more polluted, and the weather became hotter and more humid. Lastly, with regular advertising, manufacturers tried to educate consumers about the benefits of medicated skin care, as well as to encourage them to try these products. COMPETITIVE LANDSCAPE * GlaxoSmithKline was successful in keeping its leading position in medicated skin care with a 12% value share in 2010 by maintaining the popularity of its brands, Oxy, Eumovate, and Dermovate. Following closely in second position with an 11% share was Janssen Pharmaceutica, with its very successful brand Nizoral. With very active advertising activities via various media channels, Janssen Pharmaceutica successfully positioned its products as the most effective medicated shampoo and topical antifungal in the market. Thus, it attracted lots of buyers despite its premium price. PROSPECTS * Medicated skin care is predicted to see stable growth with a constant value CAGR of 2% over the forecast period. This growth is mostly bolstered by improving living standards and rising disposable incomes, together with elevating pollution in the country. Certain products, such as acne treatments and medicated shampoos, will also benefit from the rising attention for health and beauty, especially among young urban consumers. 目录 Table of Contents Medicated Skin Care in Vietnam - Category Analysis HEADLINES TRENDS • Improving living standards and higher disposable income stimulated demand for medicated skin care products among middle- and high-income consumers in Vietnam. Moreover, consumers paid more attention to medicated skin care as the environment became more and more polluted, and the weather became hotter and more humid. Lastly, with regular advertising, manufacturers tried to educate consumers about the benefits of medicated skin care, as well as to encourage them to try these products. SWITCHES COMPETITIVE LANDSCAPE • GlaxoSmithKline was successful in keeping its leading position in medicated skin care with a 12% value share in 2010 by maintaining the popularity of its brands, Oxy, Eumovate, and Dermovate. Following closely in second position with an 11% share was Janssen Pharmaceutica, with its very successful brand Nizoral. With very active advertising activities via various media channels, Janssen Pharmaceutica successfully positioned its products as the most effective medicated shampoo and topical antifungal in the market. Thus, it attracted lots of buyers despite its premium price. PROSPECTS • Medicated skin care is predicted to see stable growth with a constant value CAGR of 2% over the forecast period. This growth is mostly bolstered by improving living standards and rising disposable incomes, together with elevating pollution in the country. Certain products, such as acne treatments and medicated shampoos, will also benefit from the rising attention for health and beauty, especially among young urban consumers. CATEGORY DATA • Table 1 Sales of Medicated Skin Care by Category: Value 2005-2010 • Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010 • Table 3 Acne Treatments by Format: % Value Breakdown 2005-2010 • Table 4 Medicated Skin Care Company Shares by Value 2006-2010 • Table 5 Medicated Skin Care Brand Shares by Value 2007-2010 • Table 6 Acne Treatments Brand Shares by Value 2007-2010 • Table 7 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015 • Table 8 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015 Consumer Health in Vietnam - Industry Context EXECUTIVE SUMMARY Consumer health grew strongly in 2010 Rising demand for vitamins and dietary supplements International manufacturers dominate consumer health Chemists/pharmacies remained the key distribution channel Positive growth during the forecast period KEY TRENDS AND DEVELOPMENTS Overall growth boosted by rising incomes and growing health awareness Self-medication favoured by Vietnamese consumers Increasingly stricter price controls Domestic manufacturers established stronger presence Rising acceptance of dietary supplements MARKET INDICATORS • Table 9 Consumer Expenditure on Health Goods and Medical Services 2005-2010 • Table 10 Life Expectancy at Birth 2005-2010 MARKET DATA • Table 11 Sales of Consumer Health by Category: Value 2005-2010 • Table 12 Sales of Consumer Health by Category: % Value Growth 2005-2010 • Table 13 Consumer Health Company Shares by Value 2006-2010 • Table 14 Consumer Health Brand Shares by Value 2007-2010 • Table 15 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010 • Table 16 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010 • Table 17 Forecast Sales of Consumer Health by Category: Value 2010-2015 • Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015 APPENDIX OTC Registration and Classification Vitamins and Dietary Supplements Registration and Classification Self-medication/self-care and Preventative Medicine Switches DEFINITIONS Sources • Summary 1 Research Sources

Source: http://www.bimarket.cn/ReportFile/110816/137171.pdf